Detalles de la búsqueda
1.
P012 Ozanimod Reduced Fecal Calprotectin Levels in Patients with Ulcerative Colitis in the Phase 3 True North Study.
Am J Gastroenterol
; 115(Suppl 1): S3, 2020 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33566486
2.
Association of Adherent-invasive Escherichia coli with severe Gut Mucosal dysbiosis in Hong Kong Chinese population with Crohn's disease.
Gut Microbes
; 13(1): 1994833, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34812117
3.
Serological response to COVID-19 vaccination in IBD patients receiving biologics
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21253848
4.
Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21249889
5.
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21264916
6.
Safety of administering biologics to IBD patients at an outpatient infusion center In New York City during the COVID-19 pandemic: Sars-CoV-2 seroprevalence and clinical and social characteristics
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21253615
7.
Gastrointestinal involvement attenuates COVID-19 severity and mortality
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20187666
8.
Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2 related disease
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-109124
Resultados
1 -
8
de 8
1
Próxima >
>>